Surya Singh, M.D. To Present at American College of Gastroenterology’s Annual Scientific Meeting

Printer-friendly versionPDF version

WALTHAM, Mass. – October 3, 2008-D2Hawkeye®, Inc., the market leader in transforming healthcare data into valuable information for managing clinical risk and costs, today announced that Surya Singh, M.D., will be presenting at the American College of Gastroenterology’s Annual Scientific Meeting on October 3 – 8, 2008 in Orlando, FL. Presenting with him will be Melissa Minor, M.D., a member of the division of Gastroenterology at Brigham and Women’s Hospital.

Dr. Singh and Dr. Minor will present a study, titled “PPD Testing in Patients Starting Infliximab for Treatment of Inflammatory Bowel Disease,” which was conducted through a collaboration between D2Hawkeye, Harvard Medical School and Brigham and Women’s Hospital. The study was authored by Dr. Singh and Dr. Minor, as well as Dr. Sanjay Ghimire, a consulting physician and data mining expert at D2.

In the study, D2Hawkeye’s aggregate research database was used to examine the rate at which patients with inflammatory bowel disease placed on the TNF inhibitor infliximab are pre-screened for latent tuberculosis infection using PPD testing and chest x-rays. The D2Hawkeye database includes medical and pharmaceutical claims for more than 11 million lives between 2000 and 2007. Patients included in the analysis had two separate medical claims for Crohn’s Disease or ulcerative colitis, at least one year of continuous enrollment, and a new pharmaceutical claim for infliximab therapy (based on a 6-month look-back period). The findings from this original research will also be programmed into the D2 Medical Rules Library.

The American College of Gastroenterology’s Annual Scientific Meeting will be held at the Gaylord Palms Resort & Convention Center in Orlando, FL. The event will offer attendees the latest clinical information on various key topics, panel sessions showcasing research and studies, networking opportunities, and exhibitions featuring the latest technological and therapeutic advances in the industry.

About D2Hawkeye

D2Hawkeye (D2) is the market leader for healthcare data service solutions including data mining, decision support, clinical quality analysis, and risk analysis tools. D2 builds and manages fully-integrated medical and financial databases, applying proprietary evidence-based medical rules, and provides an intuitive, easy-to-use, ASP-based interface for medical analytics and reporting. D2’s tools are used by industry professionals to estimate cost and risk trends, identify emerging high-risk consumers for optimal allocation of medical management resources and interventions, and compare performance against industry benchmarks. D2 also provides medical advisory, medical analytics, benchmarking, and other business services on an outsourced basis. For more information, please visitwww.d2hawkeye.com.

About the American College of Gastroenterology

The American College of Gastroenterology (ACG) was founded in 1932 to advance the scientific study and medical practice of diseases of the gastrointestinal (GI) tract. The College promotes the highest standards in medical education and is guided by its commitment to meeting the individual and collective needs of clinical GI practitioners.

Contact:

Rosa Randazzo

781-693-3739

This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Contact:

Jennifer Violette

508-620-6664

This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

http://www.d2hawkeye.com/content/view/284/432/